RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Regenerative Medical Technology Group Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.04−0.00 (-5.76%)
Close on Oct 19, 2026
- Market cap
- $497.25K
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q1 FY2025 Ended Mar 31, 2025 | May 21, 2025 | Before market open | $1.35M | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 19, 2024 | Before market open | $986.31K | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 23, 2024 | Before market open | – | – | – |
Press releases
Announcements Regenerative Medical Technology filed with the SEC
TRANSCRIPT OF INVESTOR VIDEO CALL HELD ON AUGUST 20, 2026
Other events · EX-99.1 to Form 8-K
PRESS RELEASE, DATED MAY 21, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED NOVEMBER 19, 2024
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED MAY 22, 2024
Results of operations · EX-99.1 to Form 8-K
AUDITED FINANCIAL STATEMENTS FOR GLOBAL STEM CELLS GROUP, INC
Material agreement · Acquisition or disposition completed · Unregistered share sale · Executive or director change · Other events · EX-99.2 to Form 8-K/A
UNAUDITED FINANCIAL STATEMENTS FOR GLOBAL STEM CELLS GROUP, INC
Material agreement · Acquisition or disposition completed · Unregistered share sale · Executive or director change · Other events · EX-99.3 to Form 8-K/A